Coinbase CEO Brian Armstrong Says His Biotech Company Is Working On 'Extending' Human Lifespan: Here Is How They Plan To Do It

Armstrong said successful an X station that the caller venture’s extremity is to widen healthspan by restoring the relation cells had erstwhile they were younger.

“The happening that got maine excited astir that was similar each these large diseases are correlated with aging,” Armstrong shared a clip from his caller podcast with Rick Robin.

Don't Miss:

• Fast Company Calls It a ‘Groundbreaking Step for the Creator Economy' — Investors Can Still Get In astatine $0.85/Share

• GM-Backed EnergyX Is Solving the Lithium Supply Crisis — Invest Before They Scale Global Production

He argued that returning cells to their youthful relation would “automatically” sound retired the diseases that hap aboriginal successful life.

Founded successful 2021, NewLimit raised $45 cardinal successful a backing circular successful October, conscionable 5 months aft it completed its Series B round. The latest rise valued the startup astatine $1.62 billion.

The institution said that the caller superior sets the signifier for “clinical studies successful a fewer years.”

See Also: 7 Million Gamers Already Trust Gameflip With Their Digital Assets — Now You Can Own a Stake successful the Platform Before the Raise Ends 1/19

There has been a accordant effort successful caller years to make technologies that assistance boost quality lifespan.

OpenAI CEO Sam Altman invested $180 cardinal in Retro Biosciences, a institution gathering a “scalable and cost-effective” aging solution. The startup is chasing a valuation of $5 billion, according to a December study by STAT News.

Notably, shares of anti-aging and longevity probe companies took a beating successful 2025.

Read Next: 

• If determination was a caller money backed by Jeff Bezos offering a 7-9% people output with monthly dividends would you put successful it?

• Sam Altman Says AI Will Transform the Economy — This Platform Lets Investors Back Private Tech Early